Eterna Therapeutics Inc (ERNA) Stock Price

1.275 ▼ -0.005 (-0.39%)
Open: 1.275 Vol: 0 Day's range: 1.275 - 1.275 Nov 21, 10:14 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ERNA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.33▼ 1.33▼ 1.33▼ 1.39▼ 1.53▼
MA10 1.36▼ 1.40▼ 1.40▼ 1.49▼ 1.39▼
MA20 1.42▼ 1.46▼ 1.47▼ 1.56▼ 1.50▼
MA50 1.49▼ 1.55▼ 1.59▼ 1.36▼ 2.90▼
MA100 1.53▼ 1.65▼ 1.58▼ 1.51▼ 13.81▼
MA200 1.62▼ 1.54▼ 1.41▼ 2.41▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.014▼ -0.020▼ -0.019▼ -0.052▼ 0.243▲
RSI 12.280▼ 12.052▼ 16.759▼ 38.613▼ 35.547▼
STOCH 1.399▼ 1.852▼ 1.637▼ 4.196▼ 28.206    
WILL %R -100.000▼ -100.000▼ -100.000▼ -100.000▼ -89.547▼
CCI -161.696▼ -130.022▼ -129.179▼ -155.973▼ -20.127    
Latest Filters Detected On ERNA
▼ MACD $ERNA MACD(12,26,9) Crossed Below Zero Set Alert
▼ BREAK $ERNA Price Breaks 10 Days Low Set Alert
CDL $ERNA Doji Star Candlestick Pattern Detected Set Alert
CDL $ERNA Doji Candlestick Pattern Detected Set Alert
Eterna Therapeutics Inc News
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
Tuesday, November 11, 2025 04:14 AM
Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will present at Cell 2025, ...
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials
Monday, November 10, 2025 05:56 AM
The Company’s operating loss declined by 44% year-over-year, reflecting its continued laser focus on relentless execution and progress in ...
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform
Thursday, November 06, 2025 01:15 AM
CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune ...
ERNA historical stock data
date open high low close volume
21/11/25 1.275 1.275 1.275 1.275 19,201
20/11/25 1.35 1.38 1.28 1.28 52,259
19/11/25 1.45 1.47 1.37 1.39 50,400
18/11/25 1.45 1.52 1.45 1.48 28,500
17/11/25 1.48 1.5207 1.48 1.51 24,349
14/11/25 1.54 1.55 1.50 1.52 43,100
13/11/25 1.55 1.61 1.50 1.57 76,200
12/11/25 1.66 1.67 1.55 1.61 83,029
11/11/25 1.64 1.6796 1.58 1.58 55,473
10/11/25 1.67 1.75 1.63 1.67 115,719
Quote Details
52wk Low:1.09
52wk High:14.40
Vol:0
Avg Vol(3m):73.2M
1Y Chng:-78.75%
1M Chng:+2.00%
Add to Watch List
More Information
Index US Composite
Market Cap. 10.05M